Genitourinary Cancer

5:54
PROSPECT: how effective is the new prostvac vaccine against prostate cancer?
James Gulley
2:14
ASCO 2018 bladder and kidney cancer highlights
Neal Shore
3:06
Urothelial carcinoma trial updates from ASCO 2018
Bradley McGregor
3:01
Prostate cancer updates from ASCO 2018
Neal Shore
2:10
Evaluation of a DNA vaccine for prostate cancer
Neal Shore
3:25
The future of prostate cancer therapy
Karim Fizazi
1:55
CheckMate 9KD: finding novel drug combinations for patients in all stages of treatment
Karim Fizazi
2:37
LATITUDE: combination therapy for newly diagnosed prostate cancer
Karim Fizazi
4:20
Trial updates in mRCC from ASCO: KEYNOTE-427, RESORT, E2810 & IMmotion151
Toni Choueiri
1:49
Using immunotherapy wisely for prostate cancer
Gerhardt Attard
2:40
Immunotherapy in common solid tumors: an overview
Elaine Vickers
1:50
Liquid vs. tissue biopsies for prostate cancer
Gerhardt Attard
2:31
African Americans with prostate cancer respond better to abiraterone than Caucasians
Andrew Armstrong
1:05
Is a simple blood test the key to catching osteomimicry in mCRPC?
Andrew Armstrong
1:54
Osteomimicry in prostate cancer: current understanding & future targeting
Andrew Armstrong
2:21
Radical surgery for oligometastatic prostate cancer
Prasanna Sooriakumaran
VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJO needs the contact information you provide to inform you about our latest oncology news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJOncology is intended for healthcare professionals